Login to Your Account



Working Together to 'Stay in the Game'

Pharma Giants Combine HIV Pipelines into New Company

By Jennifer Boggs


Friday, April 17, 2009
Despite rumors (or perhaps hopes) that GlaxoSmithKline plc might follow recent news from Pfizer Inc. and Merck & Co. Inc. with its own mega-merger, the London-based pharma firm has opted for a more modest venture, pooling its HIV portfolio with Pfizer's in an unusual display of cooperation between pharmaceutical competitors. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription